The overall focus of my research is on the anticancer activity and immune surveillance of Natural Killer cells in cancer, as well as their interactions with other immune cells in the tumor microenvironment.
The limited treatment options available in veterinary clinics, as compared to human clinics, led me to pursue research instead of seeing patients. I've been working on evaluating the cytotoxicity of drugs on primary immune cells and tumor cells. My master's project, which focused on the anticancer effects of repurposed drugs, further piqued my curiosity about how innate immunity impacts cancer treatment. This also led me to question the use of immunodeficient mice for cancer research. Currently, I am studying the significance of NK cells in treating solid tumors with the long-term research goal of developing CAR-NK cell therapy.
We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.